re: Ann: Important GSK initiatives to new inf... Point is they don't know what to do with all the cash and have shown no inclination to return it to shareholders as a dividend or return of capital. Biotech companies get worried about cash and profits, it's not supposed to happen! Risk is they will something stupid with it like buy another company.
